183 related articles for article (PubMed ID: 37828942)
1. Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy.
Dang SW; Gao L; Li YJ; Zhang R; Xu J
Front Med (Lausanne); 2023; 10():1216412. PubMed ID: 37828942
[TBL] [Abstract][Full Text] [Related]
2. Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus.
Liu J; Wang C; Wang Y; Yao S
Diabetes Metab Syndr Obes; 2024; 17():131-142. PubMed ID: 38222031
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus.
Liu J; Wang C; Wang YT; Liu JX; Zhou TH; Yao SK; Chen G
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E62-E71. PubMed ID: 37285598
[TBL] [Abstract][Full Text] [Related]
4. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study.
Cui J; Liu Y; Li M; Yin J; Yang J; Xu L
BMC Endocr Disord; 2024 Mar; 24(1):27. PubMed ID: 38438865
[TBL] [Abstract][Full Text] [Related]
5. Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors.
Huang XJ; Yin M; Zhou BQ; Tan XY; Xia YQ; Qin CX
World J Hepatol; 2023 Aug; 15(8):985-1000. PubMed ID: 37701916
[TBL] [Abstract][Full Text] [Related]
6. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.
Zhang Y; Xiang L; Qi F; Cao Y; Zhang W; Lv T; Zhou X
Front Endocrinol (Lausanne); 2024; 15():1322563. PubMed ID: 38375190
[TBL] [Abstract][Full Text] [Related]
7. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Serum Uric Acid-to-Creatinine Ratio and the Risk of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.
Xing Y; Chen J; Liu J; Song G; Ma H
Diabetes Metab Syndr Obes; 2022; 15():257-267. PubMed ID: 35140486
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
[TBL] [Abstract][Full Text] [Related]
11. Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study.
Ma YL; Ke JF; Wang JW; Wang YJ; Xu MR; Li LX
Front Endocrinol (Lausanne); 2023; 14():1133991. PubMed ID: 37223022
[TBL] [Abstract][Full Text] [Related]
12. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.
Wang JW; Jin CH; Ke JF; Ma YL; Wang YJ; Lu JX; Li MF; Li LX
Front Endocrinol (Lausanne); 2022; 13():942412. PubMed ID: 36133303
[TBL] [Abstract][Full Text] [Related]
13. Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus.
Tang M; Wei XH; Cao H; Zhen Q; Liu F; Wang YF; Fan NG; Peng YD
Front Endocrinol (Lausanne); 2022; 13():935980. PubMed ID: 35979441
[TBL] [Abstract][Full Text] [Related]
14. Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes.
Zhang X; Chen Y; Ye H; Luo Z; Li J; Chen Z; Zhang E; Li W
Endocrine; 2023 May; 80(2):366-379. PubMed ID: 36539681
[TBL] [Abstract][Full Text] [Related]
15. Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study.
Xing Y; Chen J; Liu J; Ma H
Diabetes Metab Syndr Obes; 2022; 15():383-394. PubMed ID: 35177915
[TBL] [Abstract][Full Text] [Related]
16. [Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
Li X; Yu XM; Li EH; Chen PH; Zheng LM; Zhang S
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):987-992. PubMed ID: 37528037
[No Abstract] [Full Text] [Related]
17. Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus.
Yang J; Li CW; Zhang JR; Qiu H; Guo XL; Wang W
Diabetes Metab Syndr Obes; 2023; 16():1953-1965. PubMed ID: 37405319
[TBL] [Abstract][Full Text] [Related]
18. Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.
Guan C; Fu S; Zhen D; Yang K; An J; Wang Y; Ma C; Jiang N; Zhao N; Liu J; Yang F; Tang X
J Diabetes Res; 2022; 2022():8429847. PubMed ID: 35127953
[TBL] [Abstract][Full Text] [Related]
19. Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study.
Liu J; Duan S; Wang C; Wang Y; Peng H; Niu Z; Yao S
Front Endocrinol (Lausanne); 2022; 13():1035418. PubMed ID: 36531447
[TBL] [Abstract][Full Text] [Related]
20. Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes.
Wang YJ; Jin CH; Ke JF; Wang JW; Ma YL; Lu JX; Li MF; Li LX
Diabetes Metab Syndr Obes; 2022; 15():3717-3728. PubMed ID: 36471670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
